PRECISIONCYP
Live / Applied — Non-final action mailed (as of 22 Jun 2026)
What this means for you
Not registered yet, but its 23 Feb 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99666060
- Mark type
- Stylized text
- Filed
- 23 Feb 2026
- Attorney of record
- Laura C. Miller
Goods and services
- Class 001 — Chemicals: Assays for research purposes, namely, chemical reagents for laboratory use; assays for clinical or medical laboratory use, namely, diagnostic reagents for laboratory use; assays for detecting genotypes in clinical trials and pharmaceutical research for research purposes, namely, reagents for testing how a person metabolizes and responds to medication; assays for detecting genotypes for research purposes in the fields of pharmaceutical testing, biotechnology, medical research, and clinical trials for medical research
- Class 005 — Pharmaceuticals: Diagnostic kits for medical purposes comprising diagnostic agents, preparations and substances for medical use; Medical diagnostic assays for detecting the presence of genotypes for medical purposes; diagnostic kits for medical use comprised of medical diagnostic reagents and assays for testing for genotypes
- Class 010 — Medical apparatus: Blood testing apparatus; Diagnostic apparatus for medical purposes used in medical laboratories for testing how a person metabolizes and responds to medication
- Class 042 — Scientific and technological services: Genotyping services for research or analysis purposes
- Class 044 — Medical, beauty and agricultural services: Blood testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical testing of blood; pharmacogenetic testing services, namely, testing of blood to see how a person metabolizes and responds to medication; Blood testing services for testing how a person metabolizes and responds to medication; Genetic testing for medical purposes, namely, genotype analysis
Owner
- Laboratory Corporation of America Holdings, Burlington, NC, US
Prosecution history
- 22 Jun 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 22 Jun 2026 — NON-FINAL ACTION E-MAILED
- 22 Jun 2026 — NON-FINAL ACTION WRITTEN
- 22 Jun 2026 — ASSIGNED TO EXAMINER
- 21 Jun 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 23 Feb 2026 — APPLICATION FILING RECEIPT MAILED
- 23 Feb 2026 — NEW APPLICATION ENTERED